CN105693636B - 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 - Google Patents
具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 Download PDFInfo
- Publication number
- CN105693636B CN105693636B CN201610171185.1A CN201610171185A CN105693636B CN 105693636 B CN105693636 B CN 105693636B CN 201610171185 A CN201610171185 A CN 201610171185A CN 105693636 B CN105693636 B CN 105693636B
- Authority
- CN
- China
- Prior art keywords
- mtyp
- pure
- complex
- hmtyp
- ethyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001093 anti-cancer Effects 0.000 title abstract description 7
- 238000003786 synthesis reaction Methods 0.000 title abstract description 6
- 230000015572 biosynthetic process Effects 0.000 title description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 5
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 5
- 238000004458 analytical method Methods 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 5
- 201000007270 liver cancer Diseases 0.000 claims abstract description 5
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 5
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 5
- 239000008236 heating water Substances 0.000 claims abstract description 4
- 201000005202 lung cancer Diseases 0.000 claims abstract description 4
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 4
- -1 methoxyl group Chemical group 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 239000013078 crystal Substances 0.000 claims description 9
- 239000003446 ligand Substances 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000010189 synthetic method Methods 0.000 claims description 3
- RRTCFFFUTAGOSG-UHFFFAOYSA-N benzene;phenol Chemical compound C1=CC=CC=C1.OC1=CC=CC=C1 RRTCFFFUTAGOSG-UHFFFAOYSA-N 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000000470 constituent Substances 0.000 abstract description 2
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 abstract 2
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 abstract 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 239000000243 solution Substances 0.000 description 8
- 210000004881 tumor cell Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 239000002262 Schiff base Substances 0.000 description 3
- 150000004753 Schiff bases Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Description
C4—C3 | 1.367(4) | C10—N4 | 1.298(3) |
C4—C5 | 1.400(4) | C10—N2 | 1.348(3) |
C1—C6 | 1.417(4) | C9—N3 | 1.298(4) |
C1—C7 | 1.420(4) | C9—N2 | 1.347(3) |
C1—C2 | 1.421(4) | N2—N1 | 1.408(3) |
C5—C6 | 1.353(4) | N3—N4 | 1.384(3) |
C8—O2 | 1.420(3) | N1—C7i | 1.291(3) |
C3—O2 | 1.367(3) | N1—Cu1 | 2.001(2) |
C3—C2 | 1.428(3) | O1—Cu1 | 1.9034(17) |
C7—N1i | 1.291(3) | Cu1—O1i | 1.9034(17) |
C2—O1 | 1.296(3) | Cu1—N1i | 2.001(2) |
C3—C4—C5 | 121.2(3) | C9—N2—N1 | 128.9(2) |
C6—C1—C7 | 118.2(2) | C10—N2—N1 | 125.3(2) |
C6—C1—C2 | 120.0(2) | C9—N3—N4 | 107.5(2) |
C7—C1—C2 | 121.7(2) | C7i—N1—N2 | 114.4(2) |
C6—C5—C4 | 119.5(3) | C7i—N1—Cu1 | 124.53(18) |
O2—C3—C4 | 125.4(2) | N2—N1—Cu1 | 120.77(15) |
O2—C3—C2 | 113.5(2) | C10—N4—N3 | 106.6(2) |
C4—C3—C2 | 121.1(3) | C2—O1—Cu1 | 126.27(16) |
N1i—C7—C1 | 125.2(2) | C3—O2—C8 | 117.4(2) |
C5—C6—C1 | 121.3(3) | O1i—Cu1—O1 | 180.00(10) |
O1—C2—C1 | 124.8(2) | O1i—Cu1—N1 | 89.62(8) |
O1—C2—C3 | 118.3(2) | O1—Cu1—N1 | 90.38(8) |
C1—C2—C3 | 116.9(2) | O1i—Cu1—N1i | 90.38(8) |
N4—C10—N2 | 110.5(2) | O1—Cu1—N1i | 89.62(8) |
N3—C9—N2 | 110.0(2) | N1—Cu1—N1i | 180.0 |
C9—N2—C10 | 105.4(2) |
BEL-7404 | HepG2 | NCI-H460 | MGC80-3 | HL-7702 |
33.01±0.42 | 65.09±2.15 | 32.77±1.66 | 50.18±1.71 | 32.27±0.66 |
BEL-7404 | HepG2 | NCI-H460 | MGC80-3 | HL-7702 |
65.55±0.38 | 10.18±2.16 | 87.47±1.56 | 18.21±1.58 | 81.61±0.78 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610171185.1A CN105693636B (zh) | 2016-03-23 | 2016-03-23 | 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610171185.1A CN105693636B (zh) | 2016-03-23 | 2016-03-23 | 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105693636A CN105693636A (zh) | 2016-06-22 |
CN105693636B true CN105693636B (zh) | 2018-09-11 |
Family
ID=56232635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610171185.1A Active CN105693636B (zh) | 2016-03-23 | 2016-03-23 | 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105693636B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432286A (zh) * | 2016-09-13 | 2017-02-22 | 桂林理工大学 | 2‑吡啶甲醛衍生物席夫碱铜配合物及合成方法 |
CN106188105A (zh) * | 2016-09-13 | 2016-12-07 | 桂林理工大学 | 磁性材料水杨醛衍生物席夫碱铜配合物[Cu4(hmdo)4]·H2O及合成方法 |
CN106397461A (zh) * | 2016-09-13 | 2017-02-15 | 桂林理工大学 | 磁性材料水杨醛衍生物席夫碱铜配合物[Cu4(emdo)4]·H2O及合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1003217B (de) * | 1955-10-25 | 1957-02-28 | Bayer Ag | Verfahren zur Herstellung von Derivaten des 4-Amino-1,2,4-triazols |
JPS62270666A (ja) * | 1986-05-16 | 1987-11-25 | Konika Corp | 有機基体物質を光に対して安定化する方法 |
WO2010138820A2 (en) * | 2009-05-28 | 2010-12-02 | President And Fellows Of Harvard College | N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation |
-
2016
- 2016-03-23 CN CN201610171185.1A patent/CN105693636B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105693636A (zh) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105693636B (zh) | 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 | |
CN111187303A (zh) | 新型高抗肿瘤活性白叶藤碱铂(ii)配合物及其合成方法和应用 | |
CN107501331B (zh) | 一种抑制skov3细胞的铂配合物及其合成方法 | |
CN109908364B (zh) | 以人血清白蛋白为载体的金(iii)金属复合物的合成方法与应用 | |
CN110330534A (zh) | 一种新型2-苯基吡啶类-铂(iv)前体抗癌配合物及其合成方法和应用 | |
CN108558952A (zh) | 一种2-苯基吡啶双核钯(ii)配合物及其制备方法和应用 | |
CN105622574A (zh) | 3-苯并咪唑-2(1h)-喹啉酮衍生物及其制备方法和应用 | |
CN105198937A (zh) | 一种含有3,5-二氯水杨醛缩4-硝基邻氨基酚Schiff碱与吡啶的钴配合物及其制备方法和应用 | |
CN104650121A (zh) | 具抗癌活性的配合物[Zn(H2L2)2](H2O)5的合成及应用 | |
CN104649930B (zh) | 具抗癌活性的配合物[Zn(H2L4)2].(H2O)的合成及应用 | |
CN107488198B (zh) | 一种色胺酮铂配合物及其合成方法与应用 | |
CN102924372B (zh) | 一种抗肿瘤2-氨基-3-氰基吡啶及其应用、制备方法 | |
CN108148080B (zh) | 金属有机金(iii)配合物及其合成方法和应用 | |
CN104650157A (zh) | 具抗癌活性的配合物[Ni(H2L2)2](H2O)2的合成及应用 | |
CN105440085A (zh) | 9-苯并噻蒽腙-钌(ii)配合物及其合成方法和应用 | |
CN104447875A (zh) | 以手性化合物为配体的钌(ii)配合物及其合成方法和应用 | |
CN104447397B (zh) | 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN105753908A (zh) | 具抗癌活性的Co(mtyp)2的合成及应用 | |
CN104725429A (zh) | 具抗癌活性的配合物Mn(H2L3)2的合成及应用 | |
CN104387423A (zh) | 以手性化合物为配体的铂(ii)配合物及其合成方法和应用 | |
CN103288868B (zh) | 一种锡氧杂环结构的二丁基锡4-叔丁基苯甲酸酯及制备方法与应用 | |
CN102977081B (zh) | 胡椒乙胺缩吡啶-2-甲醛及其合成方法和应用 | |
CN102924425B (zh) | 胡椒乙胺缩3-甲基-5-氯水杨醛及其合成方法和应用 | |
CN104402762B (zh) | 具抗癌活性的3,5-二氯水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN105523961A (zh) | 一类含肉桂酰腙骨架的多甲氧基的抗肿瘤化合物的设计、合成及生物活性评价 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201218 Address after: 11 / F, Jingang building, south of Lianyungang Road, Sheyang Economic Development Zone, Sheyang County, Yancheng City, Jiangsu Province 224300 Patentee after: Li Zaigao Address before: 541004 the Guangxi Zhuang Autonomous Region Guilin Construction Road No. 12 Patentee before: GUILIN University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231122 Address after: No. 85, group 5, gaofengyan village, Gaoxing Town, Huaying City, Guang'an City, Sichuan Province Patentee after: Wang Langping Address before: 11 / F, Jingang building, south of Lianyungang Road, Sheyang Economic Development Zone, Sheyang County, Yancheng City, Jiangsu Province 224300 Patentee before: Li Zaigao |